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Context: Testicular growth represents the best clinical variable to evaluate male puberty, but 
current pediatric hormone references are based on chronological age and subjective assessments 
of discrete puberty development stages. Determination of testicular volume (TV) by ultrasound 
provides a novel approach to assess puberty progression and stratify hormone reference 
intervals. 
Objective: To establish references for serum testosterone and key hormones of the male 
pituitary-gonadal signaling pathway in relation to TV determined by ultrasound. 
Design Setting and Participants: Blood samples from 414 healthy Norwegian boys between 
6 - 16 years of age were included from the cross-sectional “Bergen Growth Study 2”. 
Participants underwent testicular ultrasound and clinical assessments and serum samples were 
analyzed by liquid chromatography tandem-mass spectrometry (LC-MS/MS) and 
immunoassays.  
Main Outcome Measures: We present references for circulating levels of total testosterone, 
luteinizing hormone (LH), follicle-stimulating hormone (FSH) and sex-hormone binding 
globulin (SHBG) in relation to TV, chronological age and Tanner pubic hair (PH) stages. 
Results: In pubertal boys, TV accounted for more variance in serum testosterone levels than 
chronological age (Spearman’s r = 0.753, p<0.001 vs r = 0.692, p<0.001, respectively). 
Continuous centile references demonstrate the association between TV and hormone levels 
during puberty. Hormone reference intervals were stratified by TV during the pubertal 
transition. 
Conclusions: Objective ultrasound assessments of TV and stratification of hormone references 
increase the diagnostic value of traditional references based on chronological age or subjective 

























Ultrasound assessments of testicular volume in Norwegian boys were leveraged to establish 

























Biochemical reference intervals are conventionally defined by the limits of the central 95% of 
the distribution within a reference population (1-3). Reliable reference limits are important to 
avoid misdiagnosis and accordingly, medical laboratories should continuously strive to verify 
and update references when new assays are implemented. The main methodological framework 
for establishing reference intervals is outlined in the proprietary Clinical Laboratory Standards 
Institute (CLSI) EP28-A3c guidelines and elsewhere (3). Whereas several clinical laboratories 
are still limited to immunoassay detection of steroid hormones such as testosterone, liquid 
chromatography tandem-mass spectrometry (LC-MS/MS) permits highly selective 
quantification of serum testosterone in the sub- to low nanomolar range. Hormone references 
are essential to identify endocrinopathies in children that exhibit abnormal progression towards 
a biochemical or developmental end-point and may require medical follow-up (4). Most 
pediatric hormone references are based on chronological age, but age is not indicative of 
physiological status during puberty. Furthermore, well-documented secular trends to earlier 
puberty timing may have implications for male reproductive health (5). 
Hormones of the hypothalamic-pituitary-gonadal (HPG) axis orchestrate the 
development of reproductive organs and sex-specific somatic traits during puberty. Pituitary-
derived follicle-stimulating hormone (FSH) and luteinizing hormone (LH) stimulate the 
development and function of spermatogenic Sertoli cells and testosterone-producing Leydig 
cells, respectively (6). The bioavailable component of circulating testosterone, unbound by sex 
hormone-binding globulin (SHBG), contributes to male fertility and secondary sex 
characteristics and provides negative feedback to the HPG signaling axis. On the somatic level, 
the traditional Tanner stages are still widely used to define pubertal progression and milestones 
of sex-specific developmental processes related to reproduction or sexual maturation (7). Prader 























The onset of male puberty is defined by attainment of testicular volume (TV) greater than 3 ml 
or equal to 4 ml when judged by traditional Prader orchidometry (8, 9). By convention, testicles 
are defined as prepubertal in the 1 - 3 ml range, pubertal in the 4 - 12 ml range and adult in the 
15 - 25 ml range. However, the clinical practice of determining male puberty onset and 
progression in terms of Tanner stages and orchidometry may be prone to inaccuracy due to the 
subjective process of assigning visual and palpative impressions to discrete ordinal stages (10, 
11). Notably, palpation systematically overestimates TV for small testicles due to the 
methodological inability to differentiate the central testicle from surrounding epididymis, 
scrotal skin and tunica capsule layers (12). Recently, ultrasound assessment of TV has been 
adopted as a modern alternative to orchidometry. Previous studies have demonstrated that data 
obtained from ultrasound determination of TV correlates accurately with traditional 
orchidometry (13-16). 
Previous studies have profiled endocrine changes throughout male puberty, but such 
studies have not considered TV (3, 17, 18) or did not succeeded in obtaining a sufficient 
population sample to estimate valid reference intervals (19). The evident ongoing decline in 
timing of puberty in the Danish population (20, 21) prompted us to benchmark male puberty 
timing in a representative sample of healthy Norwegian children. Apart from our work, the only 
previous study that reported on contemporary puberty timing in Norwegian boys was conducted 
in 1974 (22). We have recently conducted a puberty study in which TV was resolved by 
ultrasound based on our previously published radiological protocol (15). In the current study, 
we wanted to address endocrine aspects of male puberty in relation to testicular growth. 
Specifically, we aimed to establish a novel set of hormone references taking into account actual 
ultrasound-determined TV, in addition to standard age-partitioned references. 
 
























The “Bergen Growth Study 2” (BGS2) is a cross-sectional cohort study with the purpose 
of characterizing and benchmarking the timing and progression of puberty in contemporary 
Norwegian children. Subjects from six schools in the Bergen area in Western Norway were 
recruited and examined during the year 2016. A total of 491 boys between 6 and 16 years of 
age (total participation rate 36.6%) were voluntarily recruited in the study. Participants with 
known chronic diseases that could affect growth were excluded (n=6). A total of 428 boys 
consented to ultrasound examination of the testicles, of whom 19 participants were excluded 
due to findings of non-threatening scrotal  pathologies including microcalcifications, hydrocele 
or cryptorchidism (total n=19). Blood samples were acquired from 414 healthy individuals, of 
which there were 414 accounts of participant chronological age, 406 accounts of ultrasound 
testicular volume and 403 accounts of Tanner pubic hair (PH) stages. The vast majority of our 
male sample were children with two Norwegian parents (77.5%) or one or both parents from 
the European region (10%), but a minority of participants of African, Asian and Hispanic origin 
were also included to provide references for all children living in Norway. 
 
Clinical inspection and ultrasound assessment  
Tanner PH stages were visually determined with respect to the quantity, characteristics 
and distribution of pubic hair in accordance to an illustrated descriptive reference based on 
Marshall and Tanner (23). The dimensions of the right testicle were examined by one technician 
using a SonoSite Edge device (FUJIFILM SonoSite, Inc, USA) as described previously (15). 
Only in cases where the left testicle appeared visually larger than the right testicle (n=3 cases), 
the left testicle was measured by ultrasound. In the literature, consensus is that there is no 
significant difference between left and right testicular volumes in healthy males (24, 25). 























ultrasound testicular volume (TVUS) using Lambert’s equation (0.71 x L x W x D). Traditional 
Prader orchidometry defines testicle maturation intervals as pre-pubertal (<3 ml), pubertal (4 - 
12 ml) and adult (15 - 25 ml), respectively. TVUS was converted to the equivalent orchidometer 
volume (TVOM) using the non-linear formula TVOM = 1.96 x TVUS0.71 as described previously 
(15). By the reciprocal formula, equivalent intervals for TVUS measured by ultrasound were 
defined: pre-pubertal (<2.7 ml), pubertal (2.7 - 12.8 ml) and adult (>17.6 ml).  
 
Laboratory and blood sample analyses 
Blood samples were collected between 0800 and 1400 h. Isolated serum was stored at -
80°C until analysis at the Hormone Laboratory at Haukeland University Hospital, Bergen, 
Norway. The laboratory and its methods are accredited according to NS-EN ISO 15189. Total 
testosterone was assayed by LC-MS/MS using a previously published method (26). The 
analytical inter-assay coefficient of variation (CV) was 4 % in the range 1.5 – 37 nmol/L. 
Peptide hormones LH, FSH and SHBG were analyzed using the IMMULITE 2000 xpi platform 
(Siemens Healthcare, Erlangen, Germany). The analytical inter-assay CVs were 7 % at 10 IU/L 
LH, 5 % at 17 IU/L FSH and 6 % at 60 nmol/L SHBG. Free testosterone index was calculated 
as the percentage of total testosterone divided by SHBG. Standard international units were 
converted for testosterone (1 mM = 28.8 ng/dL) and SHBG (1 mM = 9.5 µg/dL). 
 
Reference intervals  
Data were processed to conform to published guidelines proposed in the CLSI EP28-
A3c guidelines and the CALIPER white paper (3). Reference intervals included a minimum of 
40 observations and ideally more than 120 observations where possible. Partitioning was based 
on clinical considerations in terms of attainment of pubertal testicle volume (≥ 4 ml TVOM by 























onset. None of the 414 healthy participants were removed as outliers from the data set. Serum 
analyte levels in respective partitions based on age, testicle volume or Tanner PH stages were 
subjected to the pairwise Harris-Boyd standard deviation test (27). For this purpose, a log 
transformation was used to obtain a Gaussian approximation when sample data were not 
intrinsically normally distributed by the Shapiro-Wilk criteria. The Harris-Boyd operation 
considers sample size (n), mean analyte value (μ) and variance (σ) of consecutive partitions. 
Pairwise partitions were considered justifiably separated only if the Harris-Boyd z score 
exceeded the corresponding ‘critical’ z* which is calculated using the  formula: z* = 
3(n1+n2/120)1/2 (28). The central 95% reference intervals and corresponding 90% confidence 
limits of the lower limits (LL) and upper limits (UL) were calculated with the nonparametric 
method when the sample size was 120 or higher or with the robust method when the sample 
size was between 40 and 120. Nonparametric calculations were based on the binomial 




The nonparametric Mann-Whitney U tests, Kruskal-Wallis one-way analysis of 
variance (ANOVA) tests and Spearman rho correlations were computed with GraphPad Prism 
v7 (GraphPad Software, San Diego, CA, USA) and SPSS (IBM Corporation, New York, NY, 
USA). P-values were not adjusted for multiple comparisons, but the number of pairwise tests is 
limited since only adjacent partitions were compared. Statistical significance was defined as 
p<0.05 (*), p<0.01 (**) or p<0.001(***). The referenceIntervals package in R (R Development 
Core Team, Vienna, Austria) was used to estimate continuous reference charts based on a 
moving window of n=40-120 observations with increments of 20 observations. Continuous 























confidence intervals associated with the 2.5th and 97.5th percentiles were calculated by 
resampling using referenceIntervals package in R and the Analyse-it (Analyse-it, Leeds, UK) 
integration in Microsoft Excel (Microsoft, Redmond, WA, USA). Figures were generated using 
R and GraphPad Prism.  
 
Ethical considerations 
This study was approved by the Norwegian Regional Ethics Committee 
(2015/128/REK, 2015/235/REK) and conformed to good clinical practice and the ethical 
standards of the Helsinki Declaration. In accordance with the regulatory specifications, children 
under the age of 16 were only examined in cases where both written informed parental consent 
and child assent was obtained. Written and informed consent was obtained according to 
regulatory protocol prior to inclusion in the cohort study. Participation in the study was 
rewarded with a cinema voucher. In cases where non-threatening scrotal pathology was 
detected by ultrasound, parents were informed and boys were referred to a pediatrician.  
 
RESULTS 
Serum hormone levels throughout puberty 
Serum concentrations of total testosterone, FSH, LH and SHBG were plotted against 
the chronological age of each study participant (Figure 1a-d). Table format references from the 
figure models are provided in Supplemental Table 1 (29). For serum testosterone levels, we 
calculated a Spearman correlation matrix to resolve associations with regard to both 
chronological age and TVUS. Overall, both chronological age and TVUS were strongly 
associated with each other (r = 0.864, p<0.001) and with testosterone levels (r = 0.876, p<0.001 
and r = 0.849, p<0.001, respectively). In prepubertal boys with TVUS < 2.7 ml, chronological 























TVUS (r = 0.420, p<0.001). In contrast, TVUS accounted for more variation in testosterone levels 
(r = 0.753, p<0.001) than age (r = 0.692, p<0.01) in pubertal boys with attained TVUS ≥ 2.7 ml. 
These findings illustrate the biological relevance of TV during puberty and prompted us to 
establish an additional set of references for hormone levels in relation to TV.  
 
Serum hormone levels and testicular volume 
Serum levels of total testosterone, FSH, LH and SHBG were plotted against a 
continuous scale of TV determined by ultrasound (Figure 2a-d). The age corresponding to 
attainment of a mean TVUS of 2.7 ml that marks the definition of puberty onset in our cohort 
was 11.7 years. Reference intervals from Figure 2 are provided in Supplemental Table 2 (29). 
 
Orchidometer references 
In order to make our results backwards compatible with traditional Prader orchidometry 
we also compiled a table to account for hormone levels in terms of TV corresponding to the 
closest discrete increment on the orchidometer TVOM scale (Table 1). We included the LH/total 
testosterone ratio as a metric of Leydig cell function to ascertain whether the definition of 
puberty onset at 4 ml TVOM or 2.7 ml TVUS would associate with a trend change of this ratio. 
Indeed, we observed that this transition was characterized by a unidirectional shift in the 
LH/Testosterone ratio, implying that serum levels of testosterone increased more rapidly than 
that of LH from this point of puberty onset. Calculations for free testosterone, unbound by 
SHBG, were also included.  
 
Serum hormone levels by Tanner PH staging 
Lastly, hormone levels were evaluated in relation to the study participants’ designated 























analyzed hormones exhibited significant median changes throughout the five Tanner PH stages 
(Kruskal-Wallis 1-way ANOVA, p < 0.0001 for all hormones). With respect to testosterone and 
SHBG, each Tanner PH stage increment was characterized by a significantly increased median 
compared to the previous stage (Mann-Whitney test, p < 0.05 for paired Tanner stage 
increments). Mean age (SD) in years ± SD for the indicated Tanner PH stages were: I 9.1 (1.7); 
II 12.1 (1.2); III 12.7 (0.9); IV 14.2 (1.1) and V 15.0 (0.7). 
 
Cohort partitions and reference intervals 
Hormone reference intervals for indicated variables and cohort partitions were 
organized in Table 2. Indicated partition pairs fulfilled the requirement for the standard deviate 
score (zSD) to exceed that of the critical sample power test (z*) based on the actual number of 
cohort observations in respective partitions, without resampling. Notably, we introduced TV as 
a covariate for the age-based reference interval 10 - <13 years. This decision was based on the 
finding that the earliest occurrences of pubertal ultrasound TVUS ≥ 2.7 ml in our dataset were 
observed from the age of 10 years. Conversely, our data included no observations of boys aged 
13 or older that exhibited prepubertal TVUS < 2.7 ml. We therefore leveraged TV as a binary 
covariate and partitioned this transition age interval with respect to whether or not the study 
participants had attained TVUS ≥ 2.7 ml, corresponding to the pediatric definition of pubertal 
onset. Importantly, these two partitions overlapping in terms of age exhibited significant median 
differences (Mann-Whitney, p < 0.001) for all hormones. As confirmed by the Harris-Boyd 
standard deviate test, this conditional partitioning of this age interval produced two separate 
and statistically valid reference intervals. Extrapolated reference intervals for Tanner PH stages 
were also included. Notably, Tanner PH stages II, III and IV were combined to obtain a 

























In this study, we combined ultrasound determination of TV with state-of-the-art LC-
MS/MS and immunoassays to respectively quantitate serum levels of testosterone and peptide 
hormones FSH, LH and SHBG. Our findings document normative endocrine changes 
associated with puberty progression in terms of both chronological age and gonadal 
development in a representative sample of contemporary and healthy Norwegian boys. We 
employed ultrasound to objectively determine testicle dimensions and calculate metric volume. 
This novel protocol presents an improvement for determining TV compared to traditional 
palpation and subjective assessments by Prader orchidometry. This is the first study to establish 
valid reference intervals for pubertal hormones in relation to ultrasound-determined TV. The 
reference intervals presented in our study are available to supplement existing diagnostic 
criteria of pediatric endocrinopathies and disorders of sexual development. 
Blood samples from healthy children are notoriously hard to obtain in large numbers 
due to ethical regulations. Accordingly, establishing empirical and valid pediatric reference 
intervals is a challenge to clinical laboratories. Determination of reference ranges on leftovers 
of in-house blood samples from children that were previously enrolled in hospital care is not 
recommended, but this remains common practice. Such population samples are likely to 
represent individuals that may hamper their suitability to serve as reference material. The data 
in our cohort is representative for regular school children and the application of exclusion 
criteria based on a clinical exam and medical history ensured a population reference sample of 
normal and healthy children. In terms of ethnicity, the current cohort is representative of the 
Norwegian general population which is comprised of approximately 90% Caucasians. This 
degree of population homogeneity may limit the generalizability of provided reference intervals 























Unlike traditional Prader orchidometry, ultrasound analysis allows for direct 
quantification of the testicle while disregarding the volume contributed by the surrounding 
epididymis. Orchidometry overestimates TV in smaller testicles where these structures are 
impossible to distinguish by palpation. Ultrasound provides an assessment of the actual testicle 
volume on a continuous scale, as opposed to the ordinal scale of the Prader orchidometer. As a 
result, the two methods produce a readout discrepancy in terms of milliliter (ml) volumes that 
empirically conform to a non-linear relationship described by the formula TVOM = 1.96 x 
TVUS0.71 (15). This allows for more refined statistical operations and modeling. In addition, 
ultrasound also has the advantage of being perceived as less personally invasive compared to 
palpation, while being able to detect testicular lesions (e.g. presence of a hydrocele or 
varicocele) or scrotal pathologies which may warrant medical attention and also confound the 
determination of TV (16). In the current study, we calculated ultrasound TVUS from testicular 
height, width and depth multiplied with a constant of 0.71 according to the Lambert equation. 
It should be noted that some studies used the standard ellipsoid formula with a constant of 0.52, 
but conversion between both methods is straightforward (15).  
A recently published Swedish study investigated the association between Prader 
orchidometer-resolved TV and serum levels of several androgen hormones including 
testosterone (19). Unfortunately, the authors did not group orchidometer volumes according to 
the established practice to distinguish the allocated prepubertal (1 - 3 ml), pubertal (4 - 12 ml) 
and adult (≥ 15 ml) stages in terms of TVOM. Additionally, the study sample size was 
insufficient to infer statistically valid hormone reference intervals.  
Sertoli cells constitute the majority volume of the adult testicle and our data 
demonstrates that serum levels of pituitary-derived FSH driving this maturation increase 
progressively from the age of 6 years. In contrast, testosterone synthesis in Leydig cells is 























the age of 10 years. Notably, we observed that the traditional definition of puberty onset at 
orchidometer TV of 4 ml indeed corresponds to the near maximal LH/testosterone ratio and 
precedes a unidirectional decline in the ratio, which may represent a critical checkpoint for 
Leydig cell maturation. Importantly, an elevated LH/testosterone ratio is a hallmark of 
Klinefelter syndrome (30). Low serum levels of testosterone, LH and FSH are clinically 
relevant for diagnosing hypogonadotropic conditions including Kallmann syndrome (31). 
Importantly, circulating testosterone is sequestered by SHBG and, to a lesser extent, albumin. 
We therefore also present data for calculated free testosterone in relation to TV.  
A limitation of the present study is the collection of non-fasting blood samples between 
0800 h and 1400 h of the day. It has previously been shown that diurnal variation in testosterone 
secretion is more pronounced in early and mid-puberty (32). However, the largest temporal 
changes in serum testosterone levels are observed during the nighttime. Interestingly, we did 
not observe significant inter-individual differences in terms of serum testosterone levels when 
comparing prepubertal (TVUS < 2.7 ml) boys grouped according in two-hour intervals of blood 
sample acquisition (Kruskal-Wallis test, p = 0.11). In contrast, pubertal boys (TVUS ≥ 2.7 ml) 
exhibited a significant decrease in testosterone levels throughout the day, unadjusted for age 
(Kruskal-Wallis, p < 0.01). Since our data are primarily based on non-fasting blood samples 
collected before noon, diurnal hormone variations and feeding effects should be considered 
when interpreting our data. Additionally, we used the IMMULITE 2000 xpi immunoassay 
platform for peptide hormone quantification. Although analytical performance of the main 
proprietary immunoassay platforms exhibit strong consistency, careful evaluation is 
recommended when implementing references that were established using a different brand 
platform (33).  
With regard to the hormone reference intervals presented in this study, we have aimed 























laboratory protocols. Although partitions should ideally be defined by 120 observations, a 
minimum sample size of 40 is sufficient to estimate a reference interval with robust resampling 
(34). The Harris-Boyd test was performed on Gaussian distributed transformed data to establish 
the validity of neighboring reference intervals. When stratifying the boys between 10 and 13 
years of age by attainment of a pubertal TVUS ≥ 2.7 ml, all hormones included Table 2 were 
satisfactorily separated by the Harris-Boyd and z* criteria. This implies that stratifying age with 
TV as a covariate is statistically warranted and may be of clinical importance.  
In conclusion, we have described the association between serum levels of pertinent 
hormones of the pituitary-gonadal hormone axis and pubertal progression in terms of testicular 
growth, chronological age and Tanner PH stages. Furthermore, we have established CLSI-
compliant reference intervals for serum levels of total testosterone, FSH, LH and SHBG based 
on a representative population sample of healthy Norwegian children. Pediatric hormone 
reference intervals may be improved by accounting for TV. By leveraging TV as a covariate, 
we were able to establish statistically valid partitions to distinguish pubertal states despite 
overlapping age.  
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Table 1. Cohort hormone levels in relation to traditional orchidometry scale.  
Ultrasound testicular volume (TVUS) was converted to the orchidometer TVOM scale using the 
non-linear formula outlined in the methods section. For each discrete increment on the 
orchidometer TVOM scale, the equivalent TVUS is provided. Cohort participants were assigned 























with the 2.5th (p2.5) and 97.5th (p97.5) percentiles are provided. Calculations for 
LH/testosterone (T) ratio and free testosterone (T) index were also included. Observations 
where TVOM was over 15 ml were discarded due to small sample size. Abbreviations: TV, 
testicular volume; SD, standard deviation; FSH, follicle-stimulating hormone; SHBG, sex 
hormone-binding globulin; T, testosterone. 
 
Table 2. Hormone reference intervals extrapolated from cohort data.  
Reference intervals for indicated hormones were established with respect to chronological age, 
ultrasound testicular volume (TVUS) and Tanner PH stages. Sample size (n) is specified for each 
partition and the standard international (SI) unit is denoted for each analyte. TVUS was used as 
a partitioning variable with age or independently to separate prepubertal (TVUS < 2.7 ml) and 
pubertal (TVUS 2.7 - 12.8 ml) individuals. Empirical cohort median (p50) hormone levels are 
presented for each partition. Significant changes in median analyte levels compared to the 
previous partition above are indicated **p<0.01 or ***p<0.001 (pairwise Mann-Whitney U 
test). Hormone reference intervals were inferred from resampled datasets based on the 
population sample. Intervals were nonparametrically defined by the 2.5th percentile lower limit 
(LL) and 97.5th percentile upper limit (UL). Lower and upper partition limits are presented with 
respective 90% confidence intervals in parentheses. Using the Harris-Boyd standard deviate 
test, each partition was tested pairwise with the pertinent and previous partition above it. Where 
the current and the previous partitions were justifiably separated, the z variable is indicated ✝. 
Abbreviations: TV, testicular volume by ultrasound; SI unit, standard international unit; LL, 
lower limit; UL, upper limit; CI, confidence interval; z, Harris-Boyd standard deviate test; 


























Figure 1. Circulating hormone levels in relation to chronological age. 
Serum levels of (a) total testosterone, (b) FSH, (c) LH and (d) SHBG from n=414 boys plotted 
against participant age. Continuous reference interval centiles indicating the moving average 
median (p50; dashed red line), lower limit (p2.5; lower black line) and upper limit (p97.5; upper 
black line) were estimated by nonparametric method in areas of n=120 observations and by the 
robust resampling method when considering n=40-120 observations in the tail ends. The 90% 
confidence intervals associated with the respective centiles are indicated as shaded area.  
 
Figure 2. Circulating hormone levels in relation to ultrasound testicular volume. 
Serum levels of (a) total testosterone, (b) FSH, (c) LH and (d) SHBG from n=409 boys plotted 
against ultrasound-determined TVUS. Continuous reference interval centiles indicate the 
moving average median (p50; dashed red line), lower limit (p2.5; lower black line) and upper 
limit (p97.5; upper black line) with shaded 90% confidence intervals. The vertical demarcation 
line indicates the cut-off for attainment of pubertal TV.  
 
Figure 3. Circulating hormone levels in relation to Tanner PH stages.  
Serum levels of (a) total testosterone, (b) FSH, (c) LH and (d) SHBG in n=412 boys in relation 
to visual determination of participant Tanner pubic hair stages I - V. Median hormone levels 
associated with each stage is indicated by the red line. The number of observations included for 


























Restrictions apply to the availability of data generated or analyzed during this study to preserve 
patient confidentiality or because they were used under license. The corresponding author will 







































































































Table 1. Cohort hormone levels in relation to traditional orchidometry scale. 




















1 0.4 37 8.1 (1.4) 0.09 (0.02 - 0.25) 0.6 (0.2 - 2.3) 0.1 (0.1 - 0.3) 120 (61 - 180) 1.75 (0.49 - 8.26) 0.07 (0.01 - 0.25) 
2 1.0 150 8.7 (1.6) 0.10 (0.02 - 0.26) 0.8 (0.2 - 2.8) 0.1 (0.1 - 0.4) 111 (52 - 180) 1.51 (0.46 - 7.78) 0.09 (0.02 - 0.29) 
3 1.8 46 10.3 (1.5) 0.17 (0.04 - 2.01) 1.5 (0.3 - 3.9) 0.3 (0.1 - 1.7) 104 (35 - 165) 1.53 (0.39 - 8.49) 0.17 (0.03 - 3.01) 
4 2.7 22 11.3 (1.2) 0.46 (0.10 - 3.87) 2.1 (0.8 - 4.1) 0.8 (0.2 - 2.9) 88 (55- 137) 1.54 (0.64 - 5.03) 0.60 (0.10 - 5,02) 
5 3.7 20 12.0 (0.9) 1.13 (0.21 - 6.07) 2.3 (1.4 - 4.3) 1.1 (0.3 - 2.5) 96 (57 - 132) 0.80 (0.23 - 2.31) 1.39 (0.25 - 7.59) 
6 4.8 19 13.1 (1.1) 2.87 (0.76 - 14.6) 2.2 (0.8 - 5.4) 1.5 (0.6 - 2.8) 81 (27 - 121) 0.45 (0.16 - 1.17) 4.87 (0.84 - 21.2) 
8 7.2 21 13.4 (1.1) 8.79 (0.89 - 16.7) 3.4 (1.7 - 8.2) 2.2 (0.8 - 7.3) 66 (29 - 115) 0.36 (0.15 - 1.04) 14.1 (0.96 - 54.2) 
10 9.9 23 14.1 (1.4) 6.18 (2.74 - 14.3) 2.8 (1.3 - 7.0) 1.8 (0.9 - 5.1) 51 (20 - 135) 0.25 (0.14 - 0.53) 10.6 (2.31 - 63.2) 
12 12.8 37 14.8 (0.9) 12.9 (4.36 - 19.9) 4.0 (1.2 - 9.8) 2.6 (1.1 - 7.0) 40 (14 - 74) 0.21 (0.09 - 0.66) 36.1 (9.39 - 88.8) 





























        Reference intervals  










06 - < 10 yrs  169 nmol/L 0.09 - 0.02 (0.01 - 0.02) 0.28 (0.19 - 0.72) - 
10 - < 13 yrs  137 nmol/L 0.28 *** 0.07 (0.06 - 0.08) 10.7 (6.85 - 13.2) ✝ 
13 - < 16 yrs  108 nmol/L 11.6 *** 1.02 (0.39 - 1.95) 22.3 (18.9 - 34.2) ✝ 
Age w/ TVUS 
10 - < 13 yrs TV < 2.7 ml 84 nmol/L 0.17 - 0.06 (0.06 - 0.08) 3.42 (0.84 - 6.01) - 
10 - < 13 yrs TV ≥ 2.7 ml 52 nmol/L 1.87 *** 0.16 (0.14 - 0.27) 12.8 (11.1 - 13.8) ✝ 
TVUS 
< 2.7 ml Prepubertal 247 nmol/L 0.11 - 0.02 (0.02 - 0.03) 0.77 (0.45 - 2.01) - 
2.7 - 12.8 ml Pubertal 115 nmol/L 4.32 *** 0.24 (0.14 - 0.48) 17.5 (16.6 - 18.7) ✝ 
Tanner PH 
I  249 nmol/L 0.11 - 0.02 (0.02 - 0.03) 2.17 (1.54 - 2.89) - 
II / III / IV  90 nmol/L 3.11 *** 0.11 (0.07 - 0.17) 18.1 (16.5 - 19.2) ✝ 






06 - < 10 yrs  169 IU/L 0.7 - 0.2 (0.1 - 0.2) 3.1 (2.4 - 4.0) - 
10 - < 13 yrs  137 IU/L 1.7 *** 0.3 (0.2 - 0.4) 4.9 (4.0 - 6.3) ✝ 
13 - < 16 yrs  108 IU/L 3.8 *** 1.3 (1.0 - 1.6) 9.7 (8.5 - 11.1) ✝ 
Age w/ TVUS 
10 - < 13 yrs TV < 2.7 ml 84 IU/L 1.4 - 0.2 (0.2 - 0.4) 4.3 (3.0 - 5.3) - 
10 - < 13 yrs TV ≥ 2.7 ml 52 IU/L 2.1 *** 0.7 (0.5 - 1.2) 6.0 (4.3 - 7.1) * 
TVUS 
< 2.7 ml Prepubertal 247 IU/L 0.8 - 0.2 (0.2 - 0.2) 3.4 (2.9 - 4.4) - 
2.7 - 12.8 ml Pubertal 115 IU/L 2.7 *** 1.1 (0.5 - 1.3) 8.9 (7.4 - 11.1) ✝ 
Tanner PH 
I  249 IU/L 0.9 - 0.2 (0.2 - 0.3) 3.7 (3.1 - 4.4) - 
II / III / IV  90 IU/L 2.6 *** 0.7 (0.5 - 1.1) 7.6 (6.7 - 9.7) ✝ 





06 - < 10 yrs  168 IU/L 0.1 - ≤ 0.1 (n/a) 0.6 (0.4 - 0.8) - 
10 - < 13 yrs  135 IU/L 0.5 *** ≤ 0.1 (n/a) 3.3 (2.2 - 4.7) ✝ 
13 - < 16 yrs  107 IU/L 2.5 *** 0.6 (0.1 - 0.97) 7.5 (6.1 - 8.7) ✝ 
Age w/ TVUS 
10 - < 13 yrs TV < 2.7 ml 83 IU/L 0.2 - ≤ 0.1 (n/a) 2.1 (1.4 - 3.7) - 
10 - < 13 yrs TV ≥ 2.7 ml 51 IU/L 1.2 *** 0.3 (0.2 - 0.5) 4.2 (2.6 - 5.0) ✝ 
TVUS 
< 2.7 ml Prepubertal 245 IU/L 0.1 - ≤ 0.1 (n/a) 1.3 (0.8 - 1.7) - 
2.7 - 12.8 ml Pubertal 114 IU/L 1.6 *** 0.4 (0.2 - 0.7) 6.6 (5.0 - 8.4) ✝ 
Tanner PH 
I  246 IU/L 0.2 - ≤ 0.1 (n/a) 1.5 (1.3 - 1.7) - 
II / III / IV  90 IU/L 1.4 *** 0.1 (0.1 - 0.2) 5.1 (4.3 - 7.0) ✝ 







06 - < 10 yrs  169 nmol/L 114 - 49 (42 - 58) ≥ 180 (n/a) - 
10 - < 13 yrs  137 nmol/L 92 *** 29 (22 - 39) 155 (142 - 174) ✝ 
13 - < 16 yrs  108 nmol/L 40 *** 13 (9 - 17) 110 (87 - 131) ✝ 
Age w/ TVUS 
10 - < 13 yrs TV < 2.7 ml 84 nmol/L 96 - 35 (20 - 60) 162 (145 - 180) - 
10 - < 13 yrs TV ≥ 2.7 ml 52 nmol/L 81 ** 27 (25 - 33) 148 (130 - 160) ✝ 
TVUS 
< 2.7 ml Prepubertal 247 nmol/L 109 - 50 (42 - 59) 179 (174 - 180) - 
2.7 - 12.8 ml Pubertal 115 nmol/L 67 *** 19 (14 -25) 133 (121 - 160) ✝ 
Tanner PH 
I  249 nmol/L 110 - 50 (42 - 58) 179 (174 - 180) - 
II / III / IV  90 nmol/L 73 *** 25 (23 - 29) 132 (121 - 143) ✝ 
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